OmniAb, Inc. (OABI)
Nasdaq: OABI · Services-Commercial Physical & Biological Research · Emeryville, CA · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Report filed | Mar 4, 2026 | Mar 18, 2025 | Mar 25, 2024 | Mar 30, 2023 | Mar 28, 2022 |
| Revenue | 18,666 | 26,391 | 34,164 | 59,077 | 34,748 |
| Research and development | 47,754 | 55,110 | 56,525 | 48,364 | 39,232 |
| General and administrative | 29,215 | 30,741 | 33,313 | 24,903 | 16,947 |
| Total operating expenses | 87,635 | 100,893 | 103,583 | 85,725 | 70,357 |
| Operating income | -68,969 | -74,502 | -69,419 | -26,648 | -35,609 |
| Interest expense | · | · | · | 0 | 7 |
| Interest and investment income | 2,660 | 3,106 | 5,055 | 587 | 0 |
| Other income (expense), net | 15 | -15 | 1 | 0 | 1,266 |
| Total non-operating income (expense) | 2,675 | 3,091 | 5,056 | 587 | 1,259 |
| Income before income taxes | -66,294 | -71,411 | -64,363 | -26,061 | -34,350 |
| Income tax expense | -1,515 | -9,378 | -13,744 | -3,727 | -7,308 |
| Net income | -64,779 | -62,033 | -50,619 | -22,334 | -27,042 |
| Earnings per share, basic | -0.57 | -0.61 | -0.51 | -0.26 | -0.33 |
| Earnings per share, diluted | -0.57 | -0.61 | -0.51 | -0.26 | -0.33 |
| Weighted average shares, basic | 113,635,000 | 102,365,000 | 99,683,000 | 85,318,000 | 82,611,789 |
| Weighted average shares, diluted | 113,635,000 | 102,365,000 | 99,683,000 | 85,318,000 | 82,611,789 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding